AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05532189 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction with BTB autograft with internal brace augmentation (suture tape)
Description: The ACL will be reconstructed using a participant's own patella tendon (BTB autograft), and the graft will be fortified by suture tape during the surgery in order to strengthen it.
Study NCT05532189 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ACL reconstruction with BTB autograft without internal brace augmentation (suture tape)
Description: The ACL will be reconstructed using a participant's own patella tendon (BTB autograft). The graft will not be fortified by suture tape in this group. It will be used as is without any modification.
Study NCT05532189 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standardized Rehabilitation Protocol
Description: Participants will undergo a standardized rehabilitation protocol with twice weekly physical therapy
Study NCT05532189 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standardized Rehabilitation Protocol
Description: Participants will undergo a standardized rehabilitation protocol with twice weekly physical therapy
Study NCT05090696 — intervention group
Intervention type: DEVICE
Intervention: Mechanical In-Exsufflator (MI-E)
Description: The feasibility will be estimated by quantifying relief and discomfort of four MI-E sessions (2 days x 2 sessions = 4 sessions). Vital signs will be also noted before and after such MI-E session.
Study NCT06268704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: This is a non-particulate steroid commonly used to treat SI joint pain.
Study NCT06268704 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone
Description: This is a particulate steroid commonly used to treat SI joint pain.
Study NCT06268704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2% Lidocaine HCl Injection
Description: Lidocaine is a local anesthetic used in SI joint injection procedures to numb the procedure site and helps to confirm SI joint dysfunction when injected with the steroid medication into the SI joint.
Study NCT06268704 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2% Lidocaine HCl Injection
Description: Lidocaine is a local anesthetic used in SI joint injection procedures to numb the procedure site and helps to confirm SI joint dysfunction when injected with the steroid medication into the SI joint.
Study NCT05642728 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Case management follow-up program
Description: The case manager will monitor asthma control (asthma control test, ACT) and adherence to treatment with questionnaires (inhaler adherence test, TAI) and electronic prescription withdrawal (e-prescription). The case manager will make decisions based on these results and according to pre-designed medical instructions. In addition, the patient will be able to contact the case manager for advice during periods of worsening symptoms. The patient will contact the case manager via a mobile app with messaging and video call option, as well as a contact phone number and email for consultations.
Study NCT06313736 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action Brings Change Project (15-minute adult version)
Description: The ABC Project is a self-guided online single-session intervention based on principles of behavioral activation. In a slightly different form intended for adolescents, it has demonstrated efficacy in several studies. Its adult version has also shown some efficacy.
Study NCT06313736 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action Brings Change Project (10-minute adult version)
Description: This is a 10-minute shortened version of the 15-minute adult version of the ABC Project. The research team created it and pilot-tested it.
Study NCT06313736 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action Brings Change Project (6-minute adult version)
Description: This is a 6-minute shortened version of the 15-minute adult version of the ABC Project. The research team created it and pilot-tested it.
Study NCT06313736 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action Brings Change Project (2-minute adult version)
Description: This is a 2-minute shortened version of the 15-minute adult version of the ABC Project. The research team created it and pilot-tested it.
Study NCT05322954 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: 25mg orally followed by 25 mg or 50 mg orally
Study NCT06172959 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vocal Intonation Therapy (VIT)
Description: Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Vocal Intonation Therapy is a music therapy technique consisting of breathing and vocal exercises to target respiratory function and vocal quality.
Study NCT06172959 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Singing (TS)
Description: Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Therapeutic Singing is a music therapy technique used to work on the rehabilitation of vocal and respiratory function.
Study NCT05970679 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: DW1125A placebo
Description: Atorvastatin 5mg placebo
Study NCT05970679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DW1125E placebo
Description: Ezetimibe 10mg placebo
Study NCT06281730 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Karl Storz New Generation Fetoscope - curved 11508AAK
Description: 11508AAK Miniature straight forward telescope 0-degree set, curved, diameter 3.3 millimeter, length 30 centimeter, 30,000 pixels, autoclavable, irrigation connector, central working channel 4 french, lateral working channel 3 French., remote eyepiece, fiber optic light transmission incorporated.
Study NCT05970679 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: DW1125E placebo
Description: Ezetimibe 10mg placebo
Study NCT05970679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DW1125A-1 placebo
Description: Atorvastatin 10mg placebo
Study NCT06281730 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Karl Storz New Generation Fetoscope - straight 11506AAK
Description: 11506AAK Miniature straight forward telescope 0-degree, straight, diameter 3.3 millimeter, length 30 cm, 30,000 pixels, autoclavable, irrigation connector, central working channel 4 french, lateral working channel 3 french, remote eyepiece, fiber optic light transmission incorporated.
Study NCT05609565 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: spinal anesthesia with hyperbaric prilocaine+adductor canal block (ACB) with bupivacaine
Description: spinal anesthesia with hyperbaric prilocaine+adductor canal block (ACB) with bupivacaine
Study NCT05970679 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: DW1125A-1 placebo
Description: Atorvastatin 10mg placebo
Study NCT05609565 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: spinal anesthesia with bupivacaine
Description: spinal anesthesia with bupivacaine
Study NCT05907785 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational intervention
Description: The intervention will consist of recommendations to improve physical activity (PA) and dietary habits. It is based on the PAIDO Programme (www.programapaido.es), an outpatient family-based multidisciplinary programme that combines PA, education on nutrition, and behavioural therapy. It will last 6 months and improvement of metabolic health and body weight loss is expected, particularly in the groups with overweight and obesity. The dietary intervention will be focused on the promotion of the Mediterranean diet, with follow-up and advice from a dietitian-nutritionist. Participants will be encouraged in reducing sedentary behaviour (watching television, playing computer games, playing board games). Performance of aerobic and strength physical exercises will be scheduled, progressively increasing the intensity. Volunteers and their parents will participate in monthly sessions to follow-up on adherence to the PA and dietary recommendations and give personalized advice.
Study NCT06208098 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Salivary cortisol dosage
Description: saliva sample at 8 - 9h \& at T30
Study NCT05880199 — intervention group
Intervention type: DEVICE
Intervention: Body surface gastric mapping device
Description: A medical device intended to record, store, view and process gastric myoelectrical activity as an aid in the diagnosis of gastrointestinal motility disorders.
Study NCT05138653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CVL-354
Description: Oral solution/suspension
Study NCT05138653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo matched to CVL-354
Study NCT05138653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CVL-354
Description: Capsule
Study NCT04607005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Description: Mepolizumab will be available as a clear to opalescent, colorless solution for SC injection in a single-use, safety syringe at a unit dose strength of 100 mg/milliliters (mL).
Study NCT04607005 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be available as a clear to opalescent, colorless sterile solution for SC injection in a single-use, safety syringe
Study NCT04607005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard of care
Description: Participants will continue to receive Standard of care as they are used to before entry in the study.
Study NCT04607005 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Standard of care
Description: Participants will continue to receive Standard of care as they are used to before entry in the study.
Study NCT05809908 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tricaprilin
Description: Each dose of IMP will be administered orally 30 minutes after completing a meal.~There is 1 g of tricaprilin per 2 ml of AC-OLE-01-VA.~Subjects will titrate from 5 g twice a day to 20 g twice a day, 40 g total daily dose of tricaprilin; 80 ml total daily dose of AC-OLE-01-VA, over the course of 3 weeks.
Study NCT05809908 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Each dose of IMP will be administered orally 30 minutes after completing a meal.~Subjects will titrate from 5 g twice a day to 20 g twice a day, 40 g total daily dose of safflower oil; 80 ml total daily dose of placebo, over the course of 3 weeks.
Study NCT06585111 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: In the first motivational interview, the HAPA Model Prenatal Motivation Interview Questionnaire, the first part of the Personal Information Form, the Prenatal Breastfeeding Self-Efficacy Scale, and the Breastfeeding Intention Scale for Pregnant Women Expecting Twins were applied. A brochure on breastfeeding twin babies prepared by the researcher was distributed to women. In the second interview, the HAPA Model Postpartum Motivation Interview Scale, the second part of which was the Personal Information Form, Breastfeeding Follow-up Form, Breastfeeding Motivation Scale and Postpartum Breastfeeding Self-Efficacy Scale were applied. In the third meeting, the Breastfeeding Follow-up Form was applied. Breastfeeding Motivation Scale, Postpartum Breastfeeding Self-Efficacy Scale and Breastfeeding Follow-up Form were applied in the fourth and fifth interviews, and Breastfeeding Follow-up Form was applied in the sixth interview.
Study NCT04659044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polatuzumab Vedotin
Description: Given IV
Study NCT04659044 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Given IV
Study NCT04659044 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab and Hyaluronidase Human
Description: Given SC
Study NCT04659044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study NCT05518812 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboprost Tromethamine
Description: During myomectomy, low-dose carboprost will be injected at the base of the fibroid and repeated as necessary. The efficacy of low-dose carboprost is being assessed, and the total dose administered will not exceed single vial for other indications.
Study NCT04258566 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optical Molecular Imaging
Description: Tracks and localizes intrahepatic lesions
Study NCT04258566 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Indocyanine Green
Description: Fluorescent dye used for visualization of cells and tissue
Study NCT04966013 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RD-X19
Description: Investigational device that uses safe electromagnetic energy to target the oropharynx.
Study NCT04966013 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Investigational device that uses safe electromagnetic energy to target the oropharynx but at energy levels with a lower inactivation potential against SARS-CoV-2 in vitro..
Study NCT05819658 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GV1001 Placebo
Description: 0.9% normal saline
Study NCT05819658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GV1001 0.56mg
Description: Lyophilized peptide from hTERT
Study NCT05819658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GV1001 1.12mg
Description: Lyophilized peptide from hTERT
Study NCT05794321 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous TXA
Description: Patients in the experimental group will receive a loading dose of tranexamic acid (TXA) at a concentration of 1g/10ml over a period of 10 minutes, administered immediately following anesthesia induction.
Study NCT05233189 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MOOC
Description: Registrants will be offered a personalized e-education consisting of 3 to 11 modules adapted to the treatment received in childhood by each in the form of a MOOC entitled Cancer in childhood, living well after over a total duration of about 3 to 7 weeks of training.
Study NCT05233189 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No intervention
Description: Patients will be followed up until 18 months only
Study NCT05331638 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prostate Cancer Genius App
Description: Participants assigned to use the Prostate Cancer Genius App will receive a combination of (a) scheduled and (b) on-demand content prostate cancer for one month. Scheduled content will be delivered on specific days each week using app notifications. Participants will also receive tailored navigation for ordering a home-based PSA kit, including receiving follow-up information from trained medical professionals about their test results.
Study NCT05331638 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: US Prevention Taskforce App
Description: Participants assigned to use the US Prevention Task Force app will download the app from Google Play and will be instructed to use the app for one-month to to become more informed about prostate cancer. They will also be instructed to download a companion app from the Google Play store. This companion app will be used to deliver weekly assessments and order a home-based PSA test kit if the participant chooses to so. Participants assigned to the Prevention Taskforce app will receive a brochure providing details about the purpose of the home-based PSA test.
Study NCT05071287 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: mHealth + low-fat diet
Description: A restricted total calorie and reduced total fat consumption.
Study NCT05071287 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mHealth + low-carb/ketogenic diet
Description: A low-carb/ketogenic diet
Study NCT06494267 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental (Video-Assisted Self-Assessment on Nasogastric Tube Insertion)
Description: Students in the experimental group will be videotaped while practicing and students will make self-evaluations.
Study NCT04287218 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TG-iConquerFear
Description: The theoretical frame of iConquerFear is based on the Common-Sense Model of illness, the Self-Regulatory Executive Function model and Relational Frame Theory. The intervention includes elements of attention training, increasing metacognitive awareness, acceptance \& mindfulness, promotion of appropriate screening behavior, and values-based goal setting. The electronic platform comprises 5 modules containing educational text, interactive exercises, short videos featuring doctors, therapists and patients' perspectives.
Study NCT04287218 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: aTAU
Description: Active control group
Study NCT06342037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tiragolumab
Description: 600mg every 3 weeks (Q3W)
Study NCT06342037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: 1200mg every 3 weeks (Q3W)
Study NCT06342037 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: 1 mg/kg, maximum of 4 cycles
Study NCT05271643 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Description: CF-CBT-A is an 10-session program for adolescents with cystic fibrosis introducing cognitive-behavioral coping skills for managing stress, and for prevention and treatment of anxiety and depression. The content of the program was developed to address stressors related to coping with cystic fibrosis. Participants will receive a patient workbook, and meet with a trained mental health clinician on their CF team who will guide them through learning and practicing coping skills. Parents/guardians involvement will be encouraged. A parent/guardian will attend the baseline and final session, have the opportunity for a mid-program check-in, and receive a workbook of psychoeducational material that parallels the adolescent workbook, featuring tips for supporting their teens, and weekly e-mail communication.
Study NCT04086927 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Unna Boot
Description: The unna boot is a zinc coated compression dressing
Study NCT05468099 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash and Povidone-Iodine
Description: Chlorhexidine mouth rinse which participants use for 20 seconds before procedure. Moreover, Povidone-Iodine nasal swabs are used to disinfect nostrils
Study NCT05468099 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High volume evacuator
Description: High volume evacuator held by assistant to capture dental spray
Study NCT05468099 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High volume evactuator and saliva ejector
Description: High volume evacuator and saliva ejector held by assistant to capture dental spray
Study NCT05468099 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Local Exhaust System
Description: Local exhaust system hovers above patient head to capture dental spray
Study NCT05083923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diroximel fumarate
Description: Administered as specified in the treatment arm
Study NCT05643495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-864
Description: Tablets for oral administration.
Study NCT06038864 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 2 clinical evaluations with 1 month in between
Description: Patients will be evaluated twice with all evaluation methods selected by the international expert group (cfr. aim 1) showing sufficient reliability and feasibility in the patient group with LLL from aim 1
Study NCT06589869 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EM Chair
Description: Patients who randomised to intervention group (Arm A) will receive HIFEM assisted (BTL EMsella) pelvic floor muscle training for total 6 sessions (2 session per week, 30 minutes per session with modulated intensity) plus standard of care. The intervention will be started within 2 weeks after Foley Catheter removed. Patients will attend follow up for training and at 1, 3 and 6 month post-operatively.
Study NCT06589869 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard of care. Perioperative education for information related to prostatectomy and pelvic floor exercise training. Patient were advice to perform pelvic floor exercise at least 30 times per day
Study NCT06596512 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PARTICS using a single ICS add on
Description: Participants randomized to PARTICS who use a nebulizer less than once a week are instructed to use the study prescribed ICS each time they use their rescue inhaler and take 5 puffs of the newly prescribed ICS after each rescue nebulizer use.
Study NCT06596512 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MART
Description: Participants are instructed to use prescribed study ICS/LABA for maintenance and as needed for rescue.
Study NCT06595186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JK-1201I
Description: JK-1201I will be administered.
Study NCT06595186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ)
Description: Temozolomide will be administered.
Study NCT06587438 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sinocare iCan I3 CGM
Description: Real-time Continuous glucose monitoring